Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

Active, not recruiting1
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

active_not_recruiting133%
not_yet_recruiting133%
unknown133%

Recent Activity

1 active trials
Showing 3 of 3
not_yet_recruiting

mNGS for IFD in Patients With Hematological Malignancies

NCT07763184
active_not_recruitingnot_applicable

Metagenomic NGS for Diagnosis of Pneumonia

NCT05979350
unknown

Diagnostic and Prognostic Value of Lung Microbiota in Early Lung Infection After Lung Transplantation

NCT05627505

Clinical Trials (3)

Showing 3 of 3 trials
NCT07763184

mNGS for IFD in Patients With Hematological Malignancies

Not Yet Recruiting
NCT05979350Not Applicable

Metagenomic NGS for Diagnosis of Pneumonia

Active Not Recruiting
NCT05627505

Diagnostic and Prognostic Value of Lung Microbiota in Early Lung Infection After Lung Transplantation

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3